& Lowdin, E. Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model. J. Antimicrob. Chemother. 68, 1319–1326 (2013). PubMed Google Scholar Adler, M., Anjum, ...
The global emergence of extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-E. coli), mainly causing urinary tract infections (UTI), is a major threat to human health. ESBL-E. coli sequence type (ST) 131 is the dominating clone worldwide, especial...
The predominant uropathogen, Escherichia coli (E. coli), is the subject of a recent article identifying the overuse of non-prescription antibiotics in Asia as a potential causative factor for the development of a new mechanism of ESBL antibiotic resistance detected in the UK [15]. Limiting the...
coli, Escherichia coli; E. faecalis, Enterococcus faecalis; ESBL, Extended spectrum beta-lactamase; H. inf, Haemophilus influenzae; KP, Klebsiella pneumoniae; MDR, Multidrug-resistant; MSRA, Methicillin-resistant Staphylococcus aureus; Ps. a, Pseudomonas aeruginosa; S/, Respiratory tract cultures; S....
Recurrent urinary tract infections (rUTIs) are extremely common, with ~ 25% of all women experiencing a recurrence within 1 year of their original infection. Escherichia coli ST131 is a globally dominant multidrug resistant clone associated with high
Case Report: Treatment of Recurrent Urosepsis Ca used by ESBL-Producing Escherichia coli with TigecyclineWolfgang A KruegerVolkhard KempfManou PeifferTorsten H Schroeder
MP23-16 ULTIMATE FATE OF RECURRENT CYSTITIS CAUSED BY ESBL-PRODUCING E.COLI; A PROSPECTIVE LONGITUDINAL STUDYPurpose: This study was designed to evaluate the efficacy of medical treatment of Peyronie's disease. Materials and methods: A total of 109 patients with Peyronie's disease who had been ...
Characterization of ESBL/pAmpC-producing Escherichia coli isolates from long-term recurrent bloodstream infectionsdoi:10.1016/j.ijantimicag.2020.106041Louise ROERFrank HANSENHenrik HASMANAnette M. HAMMERUMLina Maria CAVACOInternational Journal of Antimicrobial Agents...